Skip to main content

Nabriva Therapeutics’ latest good news soothes concerns about chief medical officer’s departure

The company’s chief medical officer said she would be leaving mere weeks before important trial results for a key drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.